{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T07:31:54Z","timestamp":1786865514150,"version":"build-2736575974"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10787-025-01816-9","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T02:37:13Z","timestamp":1750646233000},"page":"3679-3699","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Parkinson\u2019s disease: exploring the systemic immune mechanisms through molecular investigations"],"prefix":"10.1007","volume":"33","author":[{"given":"Maneesh","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashi","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"key":"1816_CR1","doi-asserted-by":"publisher","DOI":"10.1101\/2022.06.27.497828","author":"R Abdel-Haq","year":"2022","unstructured":"Abdel-Haq R, Schlachetzki JCM, Boktor JC, Cantu-Jungles TM, Thron T, Zhang M, Bostick JW, Khazaei T, Chilakala S, Morais LH, Humphrey G, Keshavarzian A, Katz JE, Thomson M, Knight R, Gradinaru V, Hamaker BR, Glass CK, Mazmanian SK (2022) A prebiotic diet modulates microglial states and motor deficits in \u03b1-Synuclein overexpressing mice. Elife. https:\/\/doi.org\/10.1101\/2022.06.27.497828","journal-title":"Elife"},{"key":"1816_CR2","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3390\/brainsci11111373","volume":"11","author":"SV Adhikarla","year":"2021","unstructured":"Adhikarla SV, Jha NK, Goswami VK, Sharma A, Bhardwaj A, Dey A, Villa C, Kumar Y, Jha SK (2021) TLR-Mediated signal transduction and neurodegenerative disorders. Brain Sci 11:1373. https:\/\/doi.org\/10.3390\/brainsci11111373","journal-title":"Brain Sci"},{"key":"1816_CR3","doi-asserted-by":"publisher","first-page":"176086","DOI":"10.1016\/j.ejphar.2023.176086","volume":"959","author":"SF Ahmad","year":"2023","unstructured":"Ahmad SF, Ansari MA, Nadeem A, Bakheet SA, Alasmari AF, Shahid M, Al-Mazroua HA, Alomar HA, AsSobeai HM, Alshamrani AA, Attia SM (2023) MAP kinase inhibitor PD98059 regulates Th1, Th9, Th17, and natural T regulatory cells in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Eur J Pharmacol 959:176086. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176086","journal-title":"Eur J Pharmacol"},{"key":"1816_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-140491","volume":"5","author":"HE Allen Reish","year":"2015","unstructured":"Allen Reish HE, Standaert DG (2015) Role of \u03b1-synuclein in inducing innate and adaptive immunity in Parkinson disease. J Parkinsons Dis 5:1\u201319. https:\/\/doi.org\/10.3233\/JPD-140491","journal-title":"J Parkinsons Dis"},{"key":"1816_CR5","doi-asserted-by":"publisher","first-page":"e160025","DOI":"10.1172\/JCI160025","volume":"133","author":"S Ando","year":"2023","unstructured":"Ando S, Perkins CM, Sajiki Y, Chastain C, Valanparambil RM, Wieland A, Hudson WH, Hashimoto M, Ramalingam SS, Freeman GJ, Ahmed R, Araki K (2023) mTOR regulates T cell exhaustion and PD-1-targeted immunotherapy response during chronic viral infection. J Clin Invest 133:e160025. https:\/\/doi.org\/10.1172\/JCI160025","journal-title":"J Clin Invest"},{"key":"1816_CR6","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-2570782\/v1","author":"HB Barsoumian","year":"2023","unstructured":"Barsoumian HB, He K, Hsu E, Bertolet G, Sezen D, Hu Y, Cortez MA, Welsh JW (2023) NLRP3 agonist enhances radiation-induced immune priming and promotes abscopal responses in anti-PD1 resistant model. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-2570782\/v1","journal-title":"Res Sq"},{"key":"1816_CR7","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.2022.36.S1.R4474","author":"F Bearoff","year":"2022","unstructured":"Bearoff F, Dhavale D, Kotzbauer P, Kortagere S (2022) Aggregated alpha-synuclein activates pro-inflammatory NFKB signaling pathways through TLR-Dependent and independent mechanisms in peripheral monocytic cells. The FASEB J. https:\/\/doi.org\/10.1096\/fasebj.2022.36.S1.R4474","journal-title":"The FASEB J"},{"key":"1816_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2022.12.006","volume":"154","author":"F Bearoff","year":"2023","unstructured":"Bearoff F, Dhavale D, Kotzbauer P, Kortagere S (2023) Aggregated alpha-synuclein transcriptionally activates pro-inflammatory canonical and non-canonical NF\u03baB signaling pathways in peripheral monocytic cells. Mol Immunol 154:1\u201310. https:\/\/doi.org\/10.1016\/j.molimm.2022.12.006","journal-title":"Mol Immunol"},{"key":"1816_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/0891988710383572","volume":"23","author":"LM Bekris","year":"2010","unstructured":"Bekris LM, Mata IF, Zabetian CP (2010) The genetics of parkinson disease. J Geriatr Psychiatry Neurol 23:228\u2013242. https:\/\/doi.org\/10.1177\/0891988710383572","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"1816_CR10","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1089\/jir.2014.0012","volume":"34","author":"EN Benveniste","year":"2014","unstructured":"Benveniste EN, Liu Y, McFarland BC, Qin H (2014) Involvement of the janus kinase\/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis. J Interferon Cytokine Res 34:577\u2013588. https:\/\/doi.org\/10.1089\/jir.2014.0012","journal-title":"J Interferon Cytokine Res"},{"key":"1816_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/jnc.15516","volume":"159","author":"NSR Bidesi","year":"2021","unstructured":"Bidesi NSR, Vang Andersen I, Windhorst AD, Shalgunov V, Herth MM (2021) The role of neuroimaging in Parkinson\u2019s disease. J Neurochem 159:660\u2013689. https:\/\/doi.org\/10.1111\/jnc.15516","journal-title":"J Neurochem"},{"key":"1816_CR12","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1038\/s41467-021-26519-x","volume":"12","author":"S Bido","year":"2021","unstructured":"Bido S, Muggeo S, Massimino L, Marzi MJ, Giannelli SG, Melacini E, Nannoni M, Gambar\u00e8 D, Bellini E, Ordazzo G, Rossi G, Maffezzini C, Iannelli A, Luoni M, Bacigaluppi M, Gregori S, Nicassio F, Broccoli V (2021) Microglia-specific overexpression of \u03b1-synuclein leads to severe dopaminergic neurodegeneration by phagocytic exhaustion and oxidative toxicity. Nat Commun 12:6237. https:\/\/doi.org\/10.1038\/s41467-021-26519-x","journal-title":"Nat Commun"},{"key":"1816_CR13","doi-asserted-by":"publisher","first-page":"1031153","DOI":"10.3389\/fncel.2022.1031153","volume":"16","author":"MM Braun","year":"2022","unstructured":"Braun MM, Puglielli L (2022) Defective PTEN-induced kinase 1\/Parkin mediated mitophagy and neurodegenerative diseases. Front Cell Neurosci 16:1031153. https:\/\/doi.org\/10.3389\/fncel.2022.1031153","journal-title":"Front Cell Neurosci"},{"key":"1816_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-375156-0.00007-2","author":"CJ Burrell","year":"2017","unstructured":"Burrell CJ, Howard CR, Murphy FA (2017) Pathogenesis of Virus Infections. Fenner White\u2019s Med Virol. https:\/\/doi.org\/10.1016\/B978-0-12-375156-0.00007-2","journal-title":"Fenner White\u2019s Med Virol"},{"key":"1816_CR15","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jnc.15349","volume":"158","author":"CA Butler","year":"2021","unstructured":"Butler CA, Thornton P, Brown GC (2021) CD33M inhibits microglial phagocytosis, migration and proliferation, but the Alzheimer\u2019s disease-protective variant CD33m stimulates phagocytosis and proliferation, and inhibits adhesion. J Neurochem 158:297\u2013310. https:\/\/doi.org\/10.1111\/jnc.15349","journal-title":"J Neurochem"},{"key":"1816_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-023-05672-9","volume":"14","author":"P Calabresi","year":"2023","unstructured":"Calabresi P, Mechelli A, Natale G, Volpicelli-Daley L, Di Lazzaro G, Ghiglieri V (2023) Alpha-synuclein in Parkinson\u2019s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction. Cell Death Dis 14:1\u201316. https:\/\/doi.org\/10.1038\/s41419-023-05672-9","journal-title":"Cell Death Dis"},{"key":"1816_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1750-1326-5-42","volume":"5","author":"S Cao","year":"2010","unstructured":"Cao S, Theodore S, Standaert DG (2010) Fc\u03b3 receptors are required for NF-\u03baB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson\u2019s disease. Mol Neurodegener 5:42. https:\/\/doi.org\/10.1186\/1750-1326-5-42","journal-title":"Mol Neurodegener"},{"key":"1816_CR18","doi-asserted-by":"publisher","first-page":"617370","DOI":"10.3389\/fnagi.2021.617370","volume":"13","author":"X Chen","year":"2021","unstructured":"Chen X, Feng W, Ou R, Liu J, Yang J, Fu J, Cao B, Chen Y, Wei Q, Shang H (2021a) Evidence for peripheral immune activation in Parkinson\u2019s disease. Front Aging Neurosci 13:617370. https:\/\/doi.org\/10.3389\/fnagi.2021.617370","journal-title":"Front Aging Neurosci"},{"key":"1816_CR19","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s12640-021-00392-4","volume":"39","author":"Y Chen","year":"2021","unstructured":"Chen Y, Jiang Y, Yang Y, Huang X, Sun C (2021b) SIRT1 protects dopaminergic neurons in Parkinson\u2019s disease models via PGC-1\u03b1-Mediated mitochondrial biogenesis. Neurotox Res 39:1393\u20131404. https:\/\/doi.org\/10.1007\/s12640-021-00392-4","journal-title":"Neurotox Res"},{"key":"1816_CR20","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41423-023-01064-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Xu Z, Sun H, Ouyang X, Han Y, Yu H, Wu N, Xie Y, Su B (2023) Regulation of CD8+ T memory and exhaustion by the mTOR signals. Cell Mol Immunol 20:1023\u20131039. https:\/\/doi.org\/10.1038\/s41423-023-01064-3","journal-title":"Cell Mol Immunol"},{"key":"1816_CR21","doi-asserted-by":"publisher","first-page":"49735","DOI":"10.18632\/oncotarget.17683","volume":"8","author":"T-Y Chuang","year":"2017","unstructured":"Chuang T-Y, Cheng A-J, Chen I-T, Lan T-Y, Huang I-H, Shiau C-W, Hsu C-L, Liu Y-W, Chang Z-F, Tseng P-H, Kuo J-C (2017) Suppression of LPS-induced inflammatory responses by the hydroxyl groups of dexamethasone. Oncotarget 8:49735\u201349748. https:\/\/doi.org\/10.18632\/oncotarget.17683","journal-title":"Oncotarget"},{"key":"1816_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.14802\/jmd.19046","volume":"12","author":"HK Chung","year":"2019","unstructured":"Chung HK, Ho H-A, P\u00e9rez-Acu\u00f1a D, Lee S-J (2019) Modeling \u03b1-Synuclein propagation with preformed fibril injections. JMD 12:139\u2013151. https:\/\/doi.org\/10.14802\/jmd.19046","journal-title":"JMD"},{"key":"1816_CR23","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.3390\/ijms25021274","volume":"25","author":"K Ciesielska-Figlon","year":"2024","unstructured":"Ciesielska-Figlon K, Lisowska KA (2024) The Role of the CD28 family receptors in T-Cell Immunomodulation. Int J Mol Sci 25:1274. https:\/\/doi.org\/10.3390\/ijms25021274","journal-title":"Int J Mol Sci"},{"key":"1816_CR24","doi-asserted-by":"publisher","first-page":"7135","DOI":"10.3390\/ijms22137135","volume":"22","author":"C Conte","year":"2021","unstructured":"Conte C (2021) Possible link between SARS-CoV-2 infection and Parkinson\u2019s disease: the role of toll-like receptor 4. Int J Mol Sci 22:7135. https:\/\/doi.org\/10.3390\/ijms22137135","journal-title":"Int J Mol Sci"},{"key":"1816_CR25","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.4103\/1673-5374.385873","volume":"19","author":"D Cossu","year":"2023","unstructured":"Cossu D, Hattori N (2023) Influence of aging, mitochondrial dysfunction, and inflammation on Parkinson\u2019s disease. Neural Regen Res 19:1197\u20131198. https:\/\/doi.org\/10.4103\/1673-5374.385873","journal-title":"Neural Regen Res"},{"key":"1816_CR26","doi-asserted-by":"publisher","first-page":"16766","DOI":"10.3390\/ijms242316766","volume":"24","author":"D Cossu","year":"2023","unstructured":"Cossu D, Hatano T, Hattori N (2023) The role of immune dysfunction in Parkinson\u2019s disease development. Int J Mol Sci 24:16766. https:\/\/doi.org\/10.3390\/ijms242316766","journal-title":"Int J Mol Sci"},{"key":"1816_CR27","doi-asserted-by":"publisher","first-page":"e286","DOI":"10.1200\/JCO.2012.41.9911","volume":"30","author":"L Dagna","year":"2012","unstructured":"Dagna L, Corti A, Langheim S, Guglielmi B, De Cobelli F, Doglioni C, Fragasso G, Sabbadini MG, Ferrarini M (2012) Tumor necrosis factor \u03b1 as a master regulator of inflammation in Erdheim-Chester disease: rationale for the treatment of patients with infliximab. J Clin Oncol 30:e286-290. https:\/\/doi.org\/10.1200\/JCO.2012.41.9911","journal-title":"J Clin Oncol"},{"key":"1816_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mito.2017.12.001","volume":"41","author":"CS Dela Cruz","year":"2018","unstructured":"Dela Cruz CS, Kang M-J (2018) Mitochondrial dysfunction and damage associated molecular patterns (DAMPs) in chronic inflammatory diseases. Mitochondrion 41:37\u201344. https:\/\/doi.org\/10.1016\/j.mito.2017.12.001","journal-title":"Mitochondrion"},{"key":"1816_CR29","doi-asserted-by":"publisher","first-page":"102251","DOI":"10.1016\/j.arr.2024.102251","volume":"95","author":"L Della Torre","year":"2024","unstructured":"Della Torre L, Beato A, Capone V, Carannante D, Verrilli G, Favale G, Del Gaudio N, Megchelenbrink WL, Benedetti R, Altucci L, Carafa V (2024) Involvement of regulated cell deaths in aging and age-related pathologies. Ageing Res Rev 95:102251. https:\/\/doi.org\/10.1016\/j.arr.2024.102251","journal-title":"Ageing Res Rev"},{"key":"1816_CR30","doi-asserted-by":"publisher","first-page":"122537","DOI":"10.1016\/j.lfs.2024.122537","volume":"342","author":"S Dhiman","year":"2024","unstructured":"Dhiman S, Mannan A, Taneja A, Mohan M, Singh TG (2024) Sirtuin dysregulation in Parkinson\u2019s disease: implications of acetylation and deacetylation processes. Life Sci 342:122537. https:\/\/doi.org\/10.1016\/j.lfs.2024.122537","journal-title":"Life Sci"},{"key":"1816_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V, Lopetuso LR, Scaldaferri F (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19:275\u2013293. https:\/\/doi.org\/10.1007\/s11739-023-03374-w","journal-title":"Intern Emerg Med"},{"key":"1816_CR32","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1089\/vim.2009.0101","volume":"23","author":"K Droebner","year":"2010","unstructured":"Droebner K, Klein B, Paxian S, Schmid R, Stitz L, Planz O (2010) The alternative NF-kappaB signalling pathway is a prerequisite for an appropriate immune response against lymphocytic choriomeningitis virus infection. Viral Immunol 23:295\u2013308. https:\/\/doi.org\/10.1089\/vim.2009.0101","journal-title":"Viral Immunol"},{"key":"1816_CR33","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1134\/S1019331622050100","volume":"92","author":"AS Dyatlova","year":"2022","unstructured":"Dyatlova AS, Novikova NS, Yushkov BG, Korneva EA, Chereshnev VA (2022) The Blood\u2212brain barrier in neuroimmune interactions and pathological processes. Her Russ Acad Sci 92:590\u2013599. https:\/\/doi.org\/10.1134\/S1019331622050100","journal-title":"Her Russ Acad Sci"},{"key":"1816_CR34","doi-asserted-by":"publisher","first-page":"NS20220063","DOI":"10.1042\/NS20220063","volume":"7","author":"N Dzamko","year":"2023","unstructured":"Dzamko N (2023) Cytokine activity in Parkinson\u2019s disease. Neuronal Signal 7:NS20220063. https:\/\/doi.org\/10.1042\/NS20220063","journal-title":"Neuronal Signal"},{"key":"1816_CR35","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.immuni.2016.01.024","volume":"44","author":"PJR Ebert","year":"2016","unstructured":"Ebert PJR, Cheung J, Yang Y, McNamara E, Hong R, Moskalenko M, Gould SE, Maecker H, Irving BA, Kim JM, Belvin M, Mellman I (2016) MAP kinase inhibition promotes T cell and anti-tumor activity in combination with PD-L1 checkpoint blockade. Immunity 44:609\u2013621. https:\/\/doi.org\/10.1016\/j.immuni.2016.01.024","journal-title":"Immunity"},{"key":"1816_CR36","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1084\/jem.187.5.763","volume":"187","author":"S Ehl","year":"1998","unstructured":"Ehl S, Hombach J, Aichele P, R\u00fclicke T, Odermatt B, Hengartner H, Zinkernagel R, Pircher H (1998) Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J Exp Med 187:763\u2013774","journal-title":"J Exp Med"},{"key":"1816_CR37","doi-asserted-by":"publisher","first-page":"7243","DOI":"10.3390\/jcm13237243","volume":"13","author":"H Eo","year":"2024","unstructured":"Eo H, Kim S, Jung UJ, Kim SR (2024) Alpha-Synuclein and microglia in Parkinson\u2019s disease: from pathogenesis to therapeutic prospects. J Clin Med 13:7243. https:\/\/doi.org\/10.3390\/jcm13237243","journal-title":"J Clin Med"},{"key":"1816_CR38","doi-asserted-by":"publisher","first-page":"115071","DOI":"10.1016\/j.expneurol.2024.115071","volume":"384","author":"M Farzan","year":"2025","unstructured":"Farzan M, Saberi-Rounkian M, Asadi-Rizi A, Heidari Z, Farzan M, Fathi M, Aghaei A, Azadegan-Dehkordi F, Bagheri N (2025) The emerging role of the microglia triggering receptor expressed on myeloid cells (TREM) 2 in multiple sclerosis. Exp Neurol 384:115071. https:\/\/doi.org\/10.1016\/j.expneurol.2024.115071","journal-title":"Exp Neurol"},{"key":"1816_CR39","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/glia.22437","volume":"61","author":"L Fellner","year":"2013","unstructured":"Fellner L, Irschick R, Schanda K, Reindl M, Klimaschewski L, Poewe W, Wenning GK, Stefanova N (2013) Toll-like receptor 4 is required for \u03b1-synuclein dependent activation of microglia and astroglia. Glia 61:349\u2013360. https:\/\/doi.org\/10.1002\/glia.22437","journal-title":"Glia"},{"key":"1816_CR40","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/jnc.13172","volume":"134","author":"Y Feng","year":"2015","unstructured":"Feng Y, Liu T, Dong S-Y, Guo Y-J, Jankovic J, Xu H, Wu Y-C (2015) Rotenone affects p53 transcriptional activity and apoptosis via targeting SIRT1 and H3K9 acetylation in SH-SY5Y cells. J Neurochem 134:668\u2013676. https:\/\/doi.org\/10.1111\/jnc.13172","journal-title":"J Neurochem"},{"key":"1816_CR41","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1124\/pr.110.004051","volume":"64","author":"JG Foster","year":"2012","unstructured":"Foster JG, Blunt MD, Carter E, Ward SG (2012) Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory\/autoimmune diseases and hematological malignancies. Pharmacol Rev 64:1027\u20131054. https:\/\/doi.org\/10.1124\/pr.110.004051","journal-title":"Pharmacol Rev"},{"key":"1816_CR42","doi-asserted-by":"publisher","first-page":"8586","DOI":"10.3390\/cimb45110540","volume":"45","author":"G Galizzi","year":"2023","unstructured":"Galizzi G, Di Carlo M (2023) Mitochondrial DNA and Inflammation in Alzheimer\u2019s Disease. Curr Issues Mol Biol 45:8586\u20138606. https:\/\/doi.org\/10.3390\/cimb45110540","journal-title":"Curr Issues Mol Biol"},{"key":"1816_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/1440-1681.13052","volume":"46","author":"P Gan","year":"2019","unstructured":"Gan P, Xia Q, Hang G, Zhou Y, Qian X, Wang X, Ding L (2019) Knockdown of cathepsin D protects dopaminergic neurons against neuroinflammation-mediated neurotoxicity through inhibition of NF-\u03baB signalling pathway in Parkinson\u2019s disease model. Clin Exp Pharmacol Physiol 46:337\u2013349. https:\/\/doi.org\/10.1111\/1440-1681.13052","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"1816_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-023-01588-0","volume":"8","author":"C Gao","year":"2023","unstructured":"Gao C, Jiang J, Tan Y, Chen S (2023a) Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Sig Transduct Target Ther 8:1\u201337. https:\/\/doi.org\/10.1038\/s41392-023-01588-0","journal-title":"Sig Transduct Target Ther"},{"key":"1816_CR45","doi-asserted-by":"publisher","first-page":"15337","DOI":"10.1002\/cam4.6195","volume":"12","author":"Y Gao","year":"2023","unstructured":"Gao Y, Feng Y, Liu S, Zhang Y, Wang J, Qin T, Chen P, Li K (2023b) Immune-independent acquired resistance to PD-L1 antibody initiated by PD-L1 upregulation via PI3K\/AKT signaling can be reversed by anlotinib. Cancer Med 12:15337\u201315349. https:\/\/doi.org\/10.1002\/cam4.6195","journal-title":"Cancer Med"},{"key":"1816_CR46","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7916\/D83777WK","volume":"5","author":"A Ghika","year":"2015","unstructured":"Ghika A, Kyrozis A, Potagas C, Louis ED (2015) Motor and non-motor features: differences between patients with isolated essential tremor and patients with both essential tremor and Parkinson\u2019s disease. Tremor Other Hyperkinet Mov (n Y) 5:335. https:\/\/doi.org\/10.7916\/D83777WK","journal-title":"Tremor Other Hyperkinet Mov (n Y)"},{"key":"1816_CR47","doi-asserted-by":"publisher","first-page":"LB","DOI":"10.1158\/1538-7445.AM2018-LB-123","volume":"78","author":"S Glaeske","year":"2018","unstructured":"Glaeske S, Huebner F, Anurin A, Janzer A, Zitzmann-Kolbe S, Paul J, Glaeske K, Berndt S, Mumberg D, Gorjanacz M, Ziegelbauer K, Kreft B, Liu N (2018) Abstract LB-123: Pulsatile inhibition of PI3K converts immune suppression by Tregs and M2-TAM to anti-tumor immune response in animal models insensitive or resistant to the monotherapies of PI3K and checkpoint inhibitors. Cancer Res 78:LB-123. https:\/\/doi.org\/10.1158\/1538-7445.AM2018-LB-123","journal-title":"Cancer Res"},{"key":"1816_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s40035-021-00271-0","volume":"10","author":"AM Gorecki","year":"2021","unstructured":"Gorecki AM, Anyaegbu CC, Anderton RS (2021) TLR2 and TLR4 in Parkinson\u2019s disease pathogenesis: the environment takes a toll on the gut. Transl Neurodegener 10:47. https:\/\/doi.org\/10.1186\/s40035-021-00271-0","journal-title":"Transl Neurodegener"},{"key":"1816_CR49","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.4049\/jimmunol.1501890","volume":"196","author":"DT Gracias","year":"2016","unstructured":"Gracias DT, Boesteanu AC, Fraietta JA, Hope JL, Carey AJ, Mueller YM, Kawalekar OU, Fike AJ, June CH, Katsikis PD (2016) Phosphatidylinositol 3-kinase p110\u03b4 isoform regulates CD8+ T cell responses during acute viral and intracellular bacterial infections. J Immunol 196:1186\u20131198. https:\/\/doi.org\/10.4049\/jimmunol.1501890","journal-title":"J Immunol"},{"key":"1816_CR50","doi-asserted-by":"publisher","first-page":"107168","DOI":"10.1016\/j.phrs.2024.107168","volume":"203","author":"R Gu","year":"2024","unstructured":"Gu R, Pan J, Awan MUN, Sun X, Yan F, Bai L, Bai J (2024) The major histocompatibility complex participates in Parkinson\u2019s disease. Pharmacol Res 203:107168. https:\/\/doi.org\/10.1016\/j.phrs.2024.107168","journal-title":"Pharmacol Res"},{"key":"1816_CR51","doi-asserted-by":"publisher","unstructured":"Hall B, Travesa A, Yamamura A, Axel A, Kolitz S, Funt J, Fowler K, Nord M, Nair P, Barrett S, Zeskind B, King P (2022). 449 Cyclic disruption of the mitogen-activated protein kinase (MAPK) pathway by the dual MEK inhibitor, IMM-6\u2013415, enhances PD1 and CTLA4 checkpoint blockade in RAS mutant tumors, in: Regular and Young Investigator Award Abstracts. Presented at the SITC 37th Annual Meeting (SITC 2022) Abstracts, BMJ Publishing Group Ltd, pp. A469\u2013A469. https:\/\/doi.org\/10.1136\/jitc-2022-SITC2022.0449","DOI":"10.1136\/jitc-2022-SITC2022.0449"},{"key":"1816_CR52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuro.2012.01.012","volume":"33","author":"GJ Harry","year":"2012","unstructured":"Harry GJ, Kraft AD (2012) Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology 33:191\u2013206. https:\/\/doi.org\/10.1016\/j.neuro.2012.01.012","journal-title":"Neurotoxicology"},{"key":"1816_CR53","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-019-1459-7","volume":"16","author":"W He","year":"2019","unstructured":"He W, Long T, Pan Q, Zhang S, Zhang Y, Zhang D, Qin G, Chen L, Zhou J (2019) Microglial NLRP3 inflammasome activation mediates IL-1\u03b2 release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. J Neuroinflammation 16:78. https:\/\/doi.org\/10.1186\/s12974-019-1459-7","journal-title":"J Neuroinflammation"},{"key":"1816_CR54","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10753-022-01762-6","volume":"46","author":"X He","year":"2023","unstructured":"He X, Xiao J, Li Z, Ye M, Lin J, Liu Z, Liang Y, Dai H, Jing R, Lin F (2023) Inhibition of PD-1 alters the SHP1\/2-PI3K\/Akt axis to decrease M1 polarization of alveolar macrophages in lung ischemia-reperfusion injury. Inflammation 46:639\u2013654. https:\/\/doi.org\/10.1007\/s10753-022-01762-6","journal-title":"Inflammation"},{"key":"1816_CR55","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","volume":"19","author":"A Heidari","year":"2022","unstructured":"Heidari A, Yazdanpanah N, Rezaei N (2022) The role of Toll-like receptors and neuroinflammation in Parkinson\u2019s disease. J Neuroinflammation 19:135. https:\/\/doi.org\/10.1186\/s12974-022-02496-w","journal-title":"J Neuroinflammation"},{"key":"1816_CR56","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.neuron.2019.12.004","volume":"105","author":"MX Henderson","year":"2020","unstructured":"Henderson MX, Sedor S, McGeary I, Cornblath EJ, Peng C, Riddle DM, Li HL, Zhang B, Brown HJ, Olufemi MF, Bassett DS, Trojanowski JQ, Lee VMY (2020) Glucocerebrosidase activity modulates neuronal susceptibility to pathological \u03b1-synuclein insult. Neuron 105:822-836.e7. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.004","journal-title":"Neuron"},{"key":"1816_CR57","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4049\/jimmunol.1601670","volume":"198","author":"MP Holt","year":"2017","unstructured":"Holt MP, Punkosdy GA, Glass DD, Shevach EM (2017) TCR signaling and CD28\/CTLA-4 signaling cooperatively modulate T regulatory cell homeostasis. J Immunol 198:1503\u20131511. https:\/\/doi.org\/10.4049\/jimmunol.1601670","journal-title":"J Immunol"},{"key":"1816_CR58","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4307273\/v1","author":"H Hong","year":"2024","unstructured":"Hong H, Wang Y, Menard M, Buckley J, Zhou L, Volpicelli-Daley L, Standaert D, Qin H, Benveniste E (2024) Suppression of the JAK\/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson\u2019s disease. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-4307273\/v1","journal-title":"Res Sq"},{"key":"1816_CR59","doi-asserted-by":"publisher","first-page":"114367","DOI":"10.1016\/j.bbr.2023.114367","volume":"445","author":"O Hsam","year":"2023","unstructured":"Hsam O, Kohl Z (2023) Serotonin in synucleinopathies. Behav Brain Res 445:114367. https:\/\/doi.org\/10.1016\/j.bbr.2023.114367","journal-title":"Behav Brain Res"},{"key":"1816_CR60","doi-asserted-by":"publisher","first-page":"111055","DOI":"10.1016\/j.brainresbull.2024.111055","volume":"216","author":"L Huang","year":"2024","unstructured":"Huang L, Li X, Li Z, Zhu H, Han Y, Zeng J, Wen M, Zeng H (2024) PD-1 mediates microglia polarization via the MAPK signaling pathway to protect blood-brain barrier function during cerebral ischemia\/reperfusion. Brain Res Bull 216:111055. https:\/\/doi.org\/10.1016\/j.brainresbull.2024.111055","journal-title":"Brain Res Bull"},{"key":"1816_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-3-1","volume":"3","author":"VC Huber","year":"2006","unstructured":"Huber VC, Mondal T, Factor SA, Seegal RF, Lawrence DA (2006) Serum antibodies from Parkinson\u2019s disease patients react with neuronal membrane proteins from a mouse dopaminergic cell line and affect its dopamine expression. J Neuroinflammation 3:1. https:\/\/doi.org\/10.1186\/1742-2094-3-1","journal-title":"J Neuroinflammation"},{"key":"1816_CR62","doi-asserted-by":"publisher","first-page":"7795","DOI":"10.1126\/scitranslmed.aai7795","volume":"10","author":"KY Hui","year":"2018","unstructured":"Hui KY, Fernandez-Hernandez H, Hu J, Schaffner A, Pankratz N, Hsu N-Y, Chuang L-S, Carmi S, Villaverde N, Li X, Rivas M, Levine AP, Bao X, Labrias PR, Haritunians T, Ruane D, Gettler K, Chen E, Li D, Schiff ER, Pontikos N, Barzilai N, Brant SR, Bressman S, Cheifetz AS, Clark LN, Daly MJ, Desnick RJ, Duerr RH, Katz S, Lencz T, Myers RH, Ostrer H, Ozelius L, Payami H, Peter Y, Rioux JD, Segal AW, Scott WK, Silverberg MS, Vance JM, Ubarretxena-Belandia I, Foroud T, Atzmon G, Pe\u2019er I, Ioannou I, McGovern DP, Yue Z, Schadt EE, Cho JH, Peter I (2018) Functional variants in LRRK2 confer pleiotropic effects on risk for Crohn\u2019s disease and Parkinson\u2019s disease. Sci Transl Med 10:7795. https:\/\/doi.org\/10.1126\/scitranslmed.aai7795","journal-title":"Sci Transl Med"},{"key":"1816_CR63","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3390\/cells12071012","volume":"12","author":"S Isik","year":"2023","unstructured":"Isik S, Yeman Kiyak B, Akbayir R, Seyhali R, Arpaci T (2023) Microglia mediated neuroinflammation in Parkinson\u2019s disease. Cells 12:1012. https:\/\/doi.org\/10.3390\/cells12071012","journal-title":"Cells"},{"key":"1816_CR64","doi-asserted-by":"publisher","first-page":"e002279","DOI":"10.1136\/jitc-2020-002279","volume":"9","author":"S Isoyama","year":"2021","unstructured":"Isoyama S, Mori S, Sugiyama D, Kojima Y, Tada Y, Shitara K, Hinohara K, Dan S, Nishikawa H (2021) Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal. J Immunother Cancer 9:e002279. https:\/\/doi.org\/10.1136\/jitc-2020-002279","journal-title":"J Immunother Cancer"},{"key":"1816_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/CritRevImmunol.v32.i1.30","volume":"32","author":"SS Iyer","year":"2012","unstructured":"Iyer SS, Cheng G (2012) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32:23\u201363","journal-title":"Crit Rev Immunol"},{"key":"1816_CR66","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuro.2018.02.013","volume":"65","author":"ME Johnson","year":"2018","unstructured":"Johnson ME, Stringer A, Bobrovskaya L (2018) Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson\u2019s disease. Neurotoxicology 65:174\u2013185. https:\/\/doi.org\/10.1016\/j.neuro.2018.02.013","journal-title":"Neurotoxicology"},{"key":"1816_CR67","doi-asserted-by":"publisher","first-page":"P001","DOI":"10.1158\/1557-3265.TARGETEDTHERAP-P001","volume":"31","author":"DP Johnson Erickson","year":"2025","unstructured":"Johnson Erickson DP, Parkman GL, Morimoto A, Shaver BA, Seitz Z, Delonais-Dick A, Cui S, Cao N, Zeng J, Sanders J, Noble WS, Wu CC, Rengan R, MacCoss MJ (2025) Abstract P001: Discovery and validation of mTOR as an immune mediator of the FLASH effect. Clin Cancer Res 31:P001. https:\/\/doi.org\/10.1158\/1557-3265.TARGETEDTHERAP-P001","journal-title":"Clin Cancer Res"},{"key":"1816_CR68","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1002\/ar.21047","volume":"292","author":"B Kaminska","year":"2009","unstructured":"Kaminska B, Gozdz A, Zawadzka M, Ellert-Miklaszewska A, Lipko M (2009) MAPK signal transduction underlying brain inflammation and gliosis as therapeutic target. Anat Rec (Hoboken) 292:1902\u20131913. https:\/\/doi.org\/10.1002\/ar.21047","journal-title":"Anat Rec (Hoboken)"},{"key":"1816_CR69","doi-asserted-by":"publisher","first-page":"5891","DOI":"10.4049\/jimmunol.0803771","volume":"182","author":"DE Kaufmann","year":"2009","unstructured":"Kaufmann DE, Walker BD (2009) PD-1 and CTLA-4 inhibitory co-signaling pathways in HIV infection and the potential for therapeutic intervention. J Immunol 182:5891\u20135897. https:\/\/doi.org\/10.4049\/jimmunol.0803771","journal-title":"J Immunol"},{"key":"1816_CR70","doi-asserted-by":"publisher","first-page":"e0275777","DOI":"10.1371\/journal.pone.0275777","volume":"17","author":"E Kaviani","year":"2022","unstructured":"Kaviani E, Hosseini A, Mahmoudi Maymand E, Ramzi M, Ghaderi A, Ramezani A (2022) Triggering of lymphocytes by CD28, 4\u20131BB, and PD-1 checkpoints to enhance the immune response capacities. PLoS ONE 17:e0275777. https:\/\/doi.org\/10.1371\/journal.pone.0275777","journal-title":"PLoS ONE"},{"key":"1816_CR71","doi-asserted-by":"publisher","first-page":"eadd0499","DOI":"10.1126\/scitranslmed.add0499","volume":"15","author":"MR Khan","year":"2023","unstructured":"Khan MR, Yin X, Kang S-U, Mitra J, Wang H, Ryu T, Brahmachari S, Karuppagounder SS, Kimura Y, Jhaldiyal A, Kim HH, Gu H, Chen R, Redding-Ochoa J, Troncoso J, Na CH, Ha T, Dawson VL, Dawson TM (2023) Enhanced mTORC1 signaling and protein synthesis in pathologic \u03b1-synuclein cellular and animal models of Parkinson\u2019s disease. Sci Transl Med 15:eadd0499. https:\/\/doi.org\/10.1126\/scitranslmed.add0499","journal-title":"Sci Transl Med"},{"key":"1816_CR72","doi-asserted-by":"publisher","first-page":"e1003722","DOI":"10.1371\/journal.ppat.1003722","volume":"9","author":"S-J Kim","year":"2013","unstructured":"Kim S-J, Khan M, Quan J, Till A, Subramani S, Siddiqui A (2013) Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis. PLoS Pathog 9:e1003722. https:\/\/doi.org\/10.1371\/journal.ppat.1003722","journal-title":"PLoS Pathog"},{"key":"1816_CR73","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.smim.2013.10.009","volume":"25","author":"M Kleinewietfeld","year":"2013","unstructured":"Kleinewietfeld M, Hafler DA (2013) The plasticity of human Treg and Th17 cells and its role in autoimmunity. Semin Immunol 25:305\u2013312. https:\/\/doi.org\/10.1016\/j.smim.2013.10.009","journal-title":"Semin Immunol"},{"key":"1816_CR74","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1742-2094-5-8","volume":"5","author":"JB Koprich","year":"2008","unstructured":"Koprich JB, Reske-Nielsen C, Mithal P, Isacson O (2008) Neuroinflammation mediated by IL-1\u03b2 increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson\u2019s disease. J Neuroinflammation 5:8. https:\/\/doi.org\/10.1186\/1742-2094-5-8","journal-title":"J Neuroinflammation"},{"key":"1816_CR75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bbi.2019.06.042","volume":"81","author":"A Kouli","year":"2019","unstructured":"Kouli A, Horne CB, Williams-Gray CH (2019) Toll-like receptors and their therapeutic potential in Parkinson\u2019s disease and \u03b1-synucleinopathies. Brain Behav Immun 81:41\u201351. https:\/\/doi.org\/10.1016\/j.bbi.2019.06.042","journal-title":"Brain Behav Immun"},{"key":"1816_CR76","doi-asserted-by":"publisher","first-page":"624597","DOI":"10.3389\/fimmu.2020.624597","volume":"11","author":"V Kumar","year":"2021","unstructured":"Kumar V (2021) The Trinity of cGAS, TLR9, and ALRs guardians of the cellular galaxy against host-derived self-DNA. Front Immunol 11:624597. https:\/\/doi.org\/10.3389\/fimmu.2020.624597","journal-title":"Front Immunol"},{"key":"1816_CR77","doi-asserted-by":"publisher","first-page":"e20231348","DOI":"10.1084\/jem.20231348","volume":"221","author":"G Lalle","year":"2024","unstructured":"Lalle G, Lautraite R, Bouherrou K, Plaschka M, Pignata A, Voisin A, Twardowski J, Perrin-Niquet M, St\u00e9phan P, Durget S, Tonon L, Ardin M, Degletagne C, Viari A, Belgarbi Dutron L, Davoust N, Postler TS, Zhao J, Caux C, Caramel J, Dalle S, Cassier PA, Klein U, Schmidt-Supprian M, Liblau R, Ghosh S, Grinberg-Bleyer Y (2024) NF-\u03baB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer. J Exp Med 221:e20231348. https:\/\/doi.org\/10.1084\/jem.20231348","journal-title":"J Exp Med"},{"key":"1816_CR78","doi-asserted-by":"publisher","first-page":"92","DOI":"10.14802\/jmd.15003","volume":"8","author":"HM Lee","year":"2015","unstructured":"Lee HM, Koh S-B (2015) Many faces of Parkinson\u2019s disease: non-motor symptoms of Parkinson\u2019s disease. J Mov Disord 8:92\u201397. https:\/\/doi.org\/10.14802\/jmd.15003","journal-title":"J Mov Disord"},{"key":"1816_CR79","doi-asserted-by":"publisher","first-page":"2015170","DOI":"10.1080\/2162402X.2021.2015170","volume":"11","author":"GJ Lee","year":"2022","unstructured":"Lee GJ, Jun Y, Jeon YK, Lee D, Lee S, Kim J (2022a) Mice transgenic for human CTLA4-CD28 fusion gene show proliferation and transformation of ATLL-like and AITL-like T cells. Oncoimmunology 11:2015170. https:\/\/doi.org\/10.1080\/2162402X.2021.2015170","journal-title":"Oncoimmunology"},{"key":"1816_CR80","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.3390\/cancers14215220","volume":"14","author":"HK Lee","year":"2022","unstructured":"Lee HK, Kim C-W, Ahn D, Go R-E, Choi Y, Choi K-C (2022b) Next-generation antisense oligonucleotide of TGF-\u03b22 enhances T Cell-mediated anticancer efficacy of anti-PD-1 therapy in a humanized mouse model of immune-excluded melanoma. Cancers (Basel) 14:5220. https:\/\/doi.org\/10.3390\/cancers14215220","journal-title":"Cancers (Basel)"},{"key":"1816_CR81","doi-asserted-by":"publisher","first-page":"1934578X2412659","DOI":"10.1177\/1934578X241265938","volume":"19","author":"JY Lee","year":"2024","unstructured":"Lee JY, Kim MJ, Choi BT, Yun YJ, Lee S-Y, Shin HK (2024) Cimifugin improves motor function through suppression of the NLRP3 inflammasome in an animal model of Parkinson\u2019s disease. Nat Prod Commun 19:1934578X241265938. https:\/\/doi.org\/10.1177\/1934578X241265938","journal-title":"Nat Prod Commun"},{"key":"1816_CR82","doi-asserted-by":"publisher","first-page":"e165544","DOI":"10.1172\/jci.insight.165544","volume":"9","author":"Z Lei","year":"2024","unstructured":"Lei Z, Tang R, Wu Y, Mao C, Xue W, Shen J, Yu J, Wang X, Qi X, Wei C, Xu L, Zhu J, Li Y, Zhang X, Ye C, Chen X, Yang X, Zhou S, Su C (2024) TGF-\u03b21 induces PD-1 expression in macrophages through SMAD3\/STAT3 cooperative signaling in chronic inflammation. JCI Insight 9:e165544. https:\/\/doi.org\/10.1172\/jci.insight.165544","journal-title":"JCI Insight"},{"key":"1816_CR83","doi-asserted-by":"publisher","first-page":"25107","DOI":"10.1074\/jbc.270.42.25107","volume":"270","author":"HT Leung","year":"1995","unstructured":"Leung HT, Bradshaw J, Cleaveland JS, Linsley PS (1995) Cytotoxic T Lymphocyte-associated molecule-4, a high avidity receptor for CD80 and CD86, contains an intracellular localization motif in its cytoplasmic tail (\u2217). J Biol Chem 270:25107\u201325114. https:\/\/doi.org\/10.1074\/jbc.270.42.25107","journal-title":"J Biol Chem"},{"key":"1816_CR84","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12917-024-03993-1","volume":"20","author":"J Li","year":"2024","unstructured":"Li J, Liu S, Dong Q, Fu Y, Sun Y, Luo R, Tian X, Guo L, Liu W, Qiu Y, Lu Q, Ye C, Zong B, Fu S (2024) PD-1\/PD-L1 axis induced host immunosuppression via PI3K\/Akt\/mTOR signalling pathway in piglets infected by Glaesserella Parasuis. BMC Vet Res 20:141. https:\/\/doi.org\/10.1186\/s12917-024-03993-1","journal-title":"BMC Vet Res"},{"key":"1816_CR85","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.4314\/tjpr.v22i9.9","volume":"22","author":"S Lin","year":"2023","unstructured":"Lin S, Yang X (2023) MAPK1 knockdown ameliorated immune and inflammatory abnormalities in a mouse model of refractory asthma. Trop J Pharm Res 22:1831\u20131840. https:\/\/doi.org\/10.4314\/tjpr.v22i9.9","journal-title":"Trop J Pharm Res"},{"key":"1816_CR86","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","volume":"9","author":"L Lin","year":"2020","unstructured":"Lin L, Lu L, Cao W, Li T (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection\u2013a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect 9:727\u2013732. https:\/\/doi.org\/10.1080\/22221751.2020.1746199","journal-title":"Emerg Microbes Infect"},{"key":"1816_CR87","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF02171745","volume":"2","author":"PS Linsley","year":"1994","unstructured":"Linsley PS (1994) Immunosuppression and the CD28 receptor. Perspect Drug Discovery des 2:221\u2013231. https:\/\/doi.org\/10.1007\/BF02171745","journal-title":"Perspect Drug Discovery des"},{"key":"1816_CR88","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1167\/iovs.14-14580","volume":"55","author":"C Liu","year":"2014","unstructured":"Liu C, Chen Y, Kochevar IE, Jurkunas UV (2014) Decreased DJ-1 leads to impaired Nrf2-regulated antioxidant defense and increased UV-A\u2013induced apoptosis in corneal endothelial cells. Invest Ophthalmol vis Sci 55:5551\u20135560. https:\/\/doi.org\/10.1167\/iovs.14-14580","journal-title":"Invest Ophthalmol vis Sci"},{"key":"1816_CR89","doi-asserted-by":"publisher","first-page":"e2102182","DOI":"10.1002\/advs.202102182","volume":"9","author":"X Liu","year":"2022","unstructured":"Liu X, Zhang W, Xu Y, Xu X, Jiang Q, Ruan J, Wu Y, Zhou Y, Saw PE, Luo B (2022) Targeting PI3K\u03b3\/AKT pathway remodels LC3-associated phagocytosis induced immunosuppression after radiofrequency ablation. Adv Sci (Weinh) 9:e2102182. https:\/\/doi.org\/10.1002\/advs.202102182","journal-title":"Adv Sci (Weinh)"},{"key":"1816_CR90","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.coi.2006.05.002","volume":"18","author":"MB Lodoen","year":"2006","unstructured":"Lodoen MB, Lanier LL (2006) Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 18:391\u2013398. https:\/\/doi.org\/10.1016\/j.coi.2006.05.002","journal-title":"Curr Opin Immunol"},{"key":"1816_CR91","doi-asserted-by":"publisher","first-page":"e1291106","DOI":"10.1080\/2162402X.2017.1291106","volume":"6","author":"C Lu","year":"2017","unstructured":"Lu C, Talukder A, Savage NM, Singh N, Liu K (2017) JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer. Oncoimmunology 6:e1291106. https:\/\/doi.org\/10.1080\/2162402X.2017.1291106","journal-title":"Oncoimmunology"},{"key":"1816_CR92","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.smim.2009.05.010","volume":"21","author":"DY Ma","year":"2009","unstructured":"Ma DY, Clark EA (2009) The role of CD40 and CD40L in dendritic cells. Semin Immunol 21:265\u2013272. https:\/\/doi.org\/10.1016\/j.smim.2009.05.010","journal-title":"Semin Immunol"},{"key":"1816_CR93","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41420-024-01844-4","volume":"10","author":"L Ma","year":"2024","unstructured":"Ma L, Han T, Zhan Y (2024) Mechanism and role of mitophagy in the development of severe infection. Cell Death Discov 10:88. https:\/\/doi.org\/10.1038\/s41420-024-01844-4","journal-title":"Cell Death Discov"},{"key":"1816_CR94","doi-asserted-by":"publisher","first-page":"9832839","DOI":"10.1155\/2016\/9832839","volume":"2016","author":"F Magrinelli","year":"2016","unstructured":"Magrinelli F, Picelli A, Tocco P, Federico A, Roncari L, Smania N, Zanette G, Tamburin S (2016) Pathophysiology of motor dysfunction in parkinson\u2019s disease as the rationale for drug treatment and rehabilitation. Parkinsons Dis 2016:9832839. https:\/\/doi.org\/10.1155\/2016\/9832839","journal-title":"Parkinsons Dis"},{"key":"1816_CR95","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3233\/JPD-150685","volume":"5","author":"P Mahlknecht","year":"2015","unstructured":"Mahlknecht P, Seppi K, Poewe W (2015) The concept of prodromal Parkinson\u2019s disease. J Parkinsons Dis 5:681\u2013697. https:\/\/doi.org\/10.3233\/JPD-150685","journal-title":"J Parkinsons Dis"},{"key":"1816_CR96","doi-asserted-by":"publisher","first-page":"111452","DOI":"10.1016\/j.cellsig.2024.111452","volume":"124","author":"A Mannan","year":"2024","unstructured":"Mannan A, Mohan M, Gulati A, Dhiman S, Singh TG (2024) Aquaporin proteins: a promising frontier for therapeutic intervention in cerebral ischemic injury. Cell Signal 124:111452. https:\/\/doi.org\/10.1016\/j.cellsig.2024.111452","journal-title":"Cell Signal"},{"key":"1816_CR97","doi-asserted-by":"publisher","first-page":"104707","DOI":"10.1016\/j.critrevonc.2025.104707","volume":"210","author":"A Mannan","year":"2025","unstructured":"Mannan A, Mohan M, Singh TG (2025) Revenge unraveling the fortress: exploring anticancer drug resistance mechanisms in BC for enhanced therapeutic strategies. Crit Rev Oncol Hematol 210:104707. https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104707","journal-title":"Crit Rev Oncol Hematol"},{"key":"1816_CR98","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EE III, Koeppen H, Astarita JL, Cubas R, Jhunjhunwala S, Banchereau R, Yang Y, Guan Y, Chalouni C, Ziai J, \u015eenbabao\u011flu Y, Santoro S, Sheinson D, Hung J, Giltnane JM, Pierce AA, Mesh K, Lianoglou S, Riegler J, Carano RAD, Eriksson P, H\u00f6glund M, Somarriba L, Halligan DL, van der Heijden MS, Loriot Y, Rosenberg JE, Fong L, Mellman I, Chen DS, Green M, Derleth C, Fine GD, Hegde PS, Bourgon R, Powles T (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554:544\u2013548. https:\/\/doi.org\/10.1038\/nature25501","journal-title":"Nature"},{"key":"1816_CR99","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2174\/0113894501320839240918110656","volume":"26","author":"M Mohan","year":"2025","unstructured":"Mohan M, Mannan A, Kakkar C, Singh TG (2025a) Nrf2 and Ferroptosis: exploring translational avenues for therapeutic approaches to neurological diseases. Curr Drug Targets 26:33\u201358. https:\/\/doi.org\/10.2174\/0113894501320839240918110656","journal-title":"Curr Drug Targets"},{"key":"1816_CR100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40495-025-00399-x","volume":"11","author":"M Mohan","year":"2025","unstructured":"Mohan M, Mannan A, Singh TG (2025b) Unveiling acid-sensing ion channels (ASICs) in neurodegeneration: implications for disease pathogenesis and therapeutic strategies. Curr Pharmacol Rep 11:19. https:\/\/doi.org\/10.1007\/s40495-025-00399-x","journal-title":"Curr Pharmacol Rep"},{"key":"1816_CR101","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11033-025-10484-5","volume":"52","author":"M Mohan","year":"2025","unstructured":"Mohan M, Mannan A, Singh TG (2025c) Unravelling the role of protein kinase R (PKR) in neurodegenerative disease: a review. Mol Biol Rep 52:377. https:\/\/doi.org\/10.1007\/s11033-025-10484-5","journal-title":"Mol Biol Rep"},{"key":"1816_CR102","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fcimb.2020.00457","volume":"10","author":"K Mohareer","year":"2020","unstructured":"Mohareer K, Medikonda J, Vadankula GR, Banerjee S (2020) Mycobacterial control of host mitochondria: bioenergetic and metabolic changes shaping cell fate and infection outcome. Front Cell Infect Microbiol 10:457. https:\/\/doi.org\/10.3389\/fcimb.2020.00457","journal-title":"Front Cell Infect Microbiol"},{"key":"1816_CR103","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","volume":"27","author":"MP Mount","year":"2007","unstructured":"Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R, Anisman H, Hayley S, Park DS (2007) Involvement of interferon-\u03b3 in microglial-mediated loss of dopaminergic neurons. J Neurosci 27:3328\u20133337. https:\/\/doi.org\/10.1523\/JNEUROSCI.5321-06.2007","journal-title":"J Neurosci"},{"key":"1816_CR104","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.3233\/JPD-223290","volume":"12","author":"LTN Nguyen","year":"2022","unstructured":"Nguyen LTN, Nguyen HD, Kim YJ, Nguyen TT, Lai TT, Lee YK, Ma H, Kim YE (2022) Role of NLRP3 Inflammasome in Parkinson\u2019s disease and therapeutic considerations. J Parkinsons Dis 12:2117\u20132133. https:\/\/doi.org\/10.3233\/JPD-223290","journal-title":"J Parkinsons Dis"},{"key":"1816_CR105","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/srep01393","volume":"3","author":"C Noelker","year":"2013","unstructured":"Noelker C, Morel L, Lescot T, Osterloh A, Alvarez-Fischer D, Breloer M, Henze C, Depboylu C, Skrzydelski D, Michel PP, Dodel RC, Lu L, Hirsch EC, Hunot S, Hartmann A (2013) Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson disease. Sci Rep 3:1393. https:\/\/doi.org\/10.1038\/srep01393","journal-title":"Sci Rep"},{"key":"1816_CR106","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/mds.27115","volume":"32","author":"JA Obeso","year":"2017","unstructured":"Obeso JA, Stamelou M, Goetz CG, Poewe W, Lang AE, Weintraub D, Burn D, Halliday GM, Bezard E, Przedborski S, Lehericy S, Brooks DJ, Rothwell JC, Hallett M, DeLong MR, Marras C, Tanner CM, Ross GW, Langston JW, Klein C, Bonifati V, Jankovic J, Lozano AM, Deuschl G, Bergman H, Tolosa E, Rodriguez-Violante M, Fahn S, Postuma RB, Berg D, Marek K, Standaert DG, Surmeier DJ, Olanow CW, Kordower JH, Calabresi P, Schapira AHV, Stoessl AJ (2017) Past, present, and future of Parkinson\u2019s disease: a special essay on the 200th anniversary of the shaking palsy. Mov Disord 32:1264\u20131310. https:\/\/doi.org\/10.1002\/mds.27115","journal-title":"Mov Disord"},{"key":"1816_CR107","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/d41586-025-00688-x","volume":"641","author":"H Okano","year":"2025","unstructured":"Okano H (2025) Clinical trials test the safety of stem-cell therapy for Parkinson\u2019s disease. Nature 641:853\u2013854. https:\/\/doi.org\/10.1038\/d41586-025-00688-x","journal-title":"Nature"},{"key":"1816_CR108","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s12035-020-02198-5","volume":"58","author":"Z Ou","year":"2021","unstructured":"Ou Z, Zhou Y, Wang L, Xue L, Zheng J, Chen L, Tong Q (2021) NLRP3 Inflammasome inhibition prevents \u03b1-Synuclein pathology by relieving autophagy dysfunction in chronic MPTP-treated NLRP3 knockout mice. Mol Neurobiol 58:1303\u20131311. https:\/\/doi.org\/10.1007\/s12035-020-02198-5","journal-title":"Mol Neurobiol"},{"key":"1816_CR109","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","volume":"9","author":"M Pajares","year":"2020","unstructured":"Pajares M, I.Rojo A, Manda G, Bosc\u00e1 L, Cuadrado A (2020) Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications. Cells 9:1687. https:\/\/doi.org\/10.3390\/cells9071687","journal-title":"Cells"},{"key":"1816_CR110","doi-asserted-by":"publisher","first-page":"10058","DOI":"10.1523\/JNEUROSCI.0302-15.2015","volume":"35","author":"N Panicker","year":"2015","unstructured":"Panicker N, Saminathan H, Jin H, Neal M, Harischandra DS, Gordon R, Kanthasamy K, Lawana V, Sarkar S, Luo J, Anantharam V, Kanthasamy AG, Kanthasamy A (2015) Fyn kinase regulates microglial neuroinflammatory responses in cell culture and animal models of Parkinson\u2019s disease. J Neurosci 35:10058\u201310077. https:\/\/doi.org\/10.1523\/JNEUROSCI.0302-15.2015","journal-title":"J Neurosci"},{"key":"1816_CR111","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","volume":"18","author":"J-S Park","year":"2018","unstructured":"Park J-S, Davis RL, Sue CM (2018) Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives. Curr Neurol Neurosci Rep 18:21. https:\/\/doi.org\/10.1007\/s11910-018-0829-3","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1816_CR112","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.3390\/cells9102277","volume":"9","author":"P Pawelec","year":"2020","unstructured":"Pawelec P, Ziemka-Nalecz M, Sypecka J, Zalewska T (2020) The impact of the CX3CL1\/CX3CR1 axis in neurological disorders. Cells 9:2277. https:\/\/doi.org\/10.3390\/cells9102277","journal-title":"Cells"},{"key":"1816_CR113","doi-asserted-by":"publisher","DOI":"10.1101\/2024.11.26.625468","author":"J Pei","year":"2024","unstructured":"Pei J, Oliveira NL, Recinto SJ, Kazanova A, Queiroz-Junior CM, Li Z, Couto K, Westfall S, King IL, Ribeiro CT, Milnerwood AJ, Desjardins M, Thanabalasuriar A, Stratton JA, Gruenheid S (2024) LRRK2 G2019S mutation incites increased cell-intrinsic neutrophil effector functions and intestinal inflammation in a model of infectious colitis. BioRxiv. https:\/\/doi.org\/10.1101\/2024.11.26.625468","journal-title":"BioRxiv"},{"key":"1816_CR114","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/glia.23970","volume":"69","author":"AF Pike","year":"2021","unstructured":"Pike AF, Varanita T, Herrebout MAC, Plug BC, Kole J, Musters RJP, Teunissen CE, Hoozemans JJM, Bubacco L, Veerhuis R (2021) \u03b1-Synuclein evokes NLRP3 inflammasome-mediated IL-1\u03b2 secretion from primary human microglia. Glia 69:1413\u20131428. https:\/\/doi.org\/10.1002\/glia.23970","journal-title":"Glia"},{"key":"1816_CR115","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-023-00626-6","volume":"10","author":"SC Pike","year":"2024","unstructured":"Pike SC, Havrda M, Gilli F, Zhang Z, Salas LA (2024) Immunological shifts during early-stage Parkinson\u2019s disease identified with DNA methylation data on longitudinally collected blood samples. NPJ Parkinsons Dis 10:21. https:\/\/doi.org\/10.1038\/s41531-023-00626-6","journal-title":"NPJ Parkinsons Dis"},{"key":"1816_CR116","doi-asserted-by":"publisher","first-page":"106156","DOI":"10.1016\/j.nbd.2023.106156","volume":"183","author":"C Qi","year":"2023","unstructured":"Qi C, Liu Q (2023) Natural killer cells in aging and age-related diseases. Neurobiol Dis 183:106156. https:\/\/doi.org\/10.1016\/j.nbd.2023.106156","journal-title":"Neurobiol Dis"},{"key":"1816_CR117","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12974-018-1236-z","volume":"15","author":"C Qiao","year":"2018","unstructured":"Qiao C, Zhang Q, Jiang Q, Zhang T, Chen M, Fan Y, Ding J, Lu M, Hu G (2018) Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP\/p mouse model of Parkinson\u2019s disease. J Neuroinflammation 15:193. https:\/\/doi.org\/10.1186\/s12974-018-1236-z","journal-title":"J Neuroinflammation"},{"key":"1816_CR118","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.192.Supp.201.3","author":"H Qin","year":"2014","unstructured":"Qin H, Buckley J, Liu Y, Holdbrooks A, Benveniste E (2014) Targeting the JAK\/STAT pathway in the treatment of Parkinson\u2019s disease (THER6P847). J Immunology. https:\/\/doi.org\/10.4049\/jimmunol.192.Supp.201.3","journal-title":"J Immunology"},{"key":"1816_CR119","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1523\/JNEUROSCI.4658-15.2016","volume":"36","author":"H Qin","year":"2016","unstructured":"Qin H, Buckley JA, Li X, Liu Y, Fox TH, Meares GP, Yu H, Yan Z, Harms AS, Li Y, Standaert DG, Benveniste EN (2016) Inhibition of the JAK\/STAT pathway protects against \u03b1-Synuclein-induced neuroinflammation and dopaminergic neurodegeneration. J Neurosci 36:5144\u20135159. https:\/\/doi.org\/10.1523\/JNEUROSCI.4658-15.2016","journal-title":"J Neurosci"},{"key":"1816_CR120","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s40478-020-01062-w","volume":"8","author":"PMJ Quinn","year":"2020","unstructured":"Quinn PMJ, Moreira PI, Ambr\u00f3sio AF, Alves CH (2020) PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathol Commun 8:189. https:\/\/doi.org\/10.1186\/s40478-020-01062-w","journal-title":"Acta Neuropathol Commun"},{"key":"1816_CR121","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3934\/Neuroscience.2023017","volume":"10","author":"S Ramesh","year":"2023","unstructured":"Ramesh S, Arachchige ASPM (2023) Depletion of dopamine in Parkinson\u2019s disease and relevant therapeutic options: a review of the literature. AIMS Neurosci 10:200\u2013231. https:\/\/doi.org\/10.3934\/Neuroscience.2023017","journal-title":"AIMS Neurosci"},{"key":"1816_CR122","doi-asserted-by":"publisher","first-page":"e2350548","DOI":"10.1002\/eji.202350548","volume":"54","author":"CN Rau","year":"2024","unstructured":"Rau CN, Severin ME, Lee PW, Deffenbaugh JL, Liu Y, Murphy SP, Petersen-Cherubini CL, Lovett-Racke AE (2024) MicroRNAs targeting TGF-\u03b2 signaling exacerbate central nervous system autoimmunity by disrupting regulatory T cell development and function. Eur J Immunol 54:e2350548. https:\/\/doi.org\/10.1002\/eji.202350548","journal-title":"Eur J Immunol"},{"key":"1816_CR123","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-8118-8-3","volume":"8","author":"Z Redzic","year":"2011","unstructured":"Redzic Z (2011) Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS 8:3. https:\/\/doi.org\/10.1186\/2045-8118-8-3","journal-title":"Fluids Barriers CNS"},{"key":"1816_CR124","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fneur.2017.00037","volume":"8","author":"CD Rietdijk","year":"2017","unstructured":"Rietdijk CD, Perez-Pardo P, Garssen J, van Wezel RJA, Kraneveld AD (2017) Exploring Braak\u2019s hypothesis of Parkinson\u2019s disease. Front Neurol 8:37. https:\/\/doi.org\/10.3389\/fneur.2017.00037","journal-title":"Front Neurol"},{"key":"1816_CR125","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3390\/life11080767","volume":"11","author":"C Rinaldi","year":"2021","unstructured":"Rinaldi C, Donato L, Alibrandi S, Scimone C, D\u2019Angelo R, Sidoti A (2021) Oxidative stress and the neurovascular unit. Life (Basel) 11:767. https:\/\/doi.org\/10.3390\/life11080767","journal-title":"Life (Basel)"},{"key":"1816_CR126","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1002\/glia.24385","volume":"71","author":"SM Rocha","year":"2023","unstructured":"Rocha SM, Kirkley KS, Chatterjee D, Aboellail TA, Smeyne RJ, Tjalkens RB (2023) Microglia-specific knock-out of NF-\u03baB\/IKK2 increases the accumulation of misfolded \u03b1-synuclein through the inhibition of p62\/sequestosome-1-dependent autophagy in the rotenone model of Parkinson\u2019s disease. Glia 71:2154\u20132179. https:\/\/doi.org\/10.1002\/glia.24385","journal-title":"Glia"},{"key":"1816_CR127","doi-asserted-by":"publisher","first-page":"E1178","DOI":"10.1073\/pnas.1611299114","volume":"114","author":"A Rogel","year":"2017","unstructured":"Rogel A, Willoughby JE, Buchan SL, Leonard HJ, Thirdborough SM, Al-Shamkhani A (2017) Akt signaling is critical for memory CD8+ T-cell development and tumor immune surveillance. Proc Natl Acad Sci U S A 114:E1178\u2013E1187. https:\/\/doi.org\/10.1073\/pnas.1611299114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1816_CR128","doi-asserted-by":"publisher","first-page":"104758","DOI":"10.1016\/j.cellimm.2023.104758","volume":"391\u2013392","author":"S Roy","year":"2023","unstructured":"Roy S, Gupta AK, Banerjee M, Das PK, Ukil A (2023) PD-1 negatively tunes macrophage immune activation by turning off JNK and STAT1 signaling: exploited by leishmania for its intra-macrophage survival. Cell Immunol 391\u2013392:104758. https:\/\/doi.org\/10.1016\/j.cellimm.2023.104758","journal-title":"Cell Immunol"},{"key":"1816_CR129","doi-asserted-by":"publisher","first-page":"105724","DOI":"10.1016\/j.nbd.2022.105724","volume":"169","author":"I Russo","year":"2022","unstructured":"Russo I, Bubacco L, Greggio E (2022) LRRK2 as a target for modulating immune system responses. Neurobiol Dis 169:105724. https:\/\/doi.org\/10.1016\/j.nbd.2022.105724","journal-title":"Neurobiol Dis"},{"key":"1816_CR130","doi-asserted-by":"publisher","first-page":"122393","DOI":"10.1016\/j.lfs.2023.122393","volume":"339","author":"NS Sadier","year":"2024","unstructured":"Sadier NS, El Hajjar F, Al Sabouri AAK, Abou-Abbas L, Siomava N, Almutary AG, Tambuwala MM (2024) Irisin: an unveiled bridge between physical exercise and a healthy brain. Life Sci 339:122393. https:\/\/doi.org\/10.1016\/j.lfs.2023.122393","journal-title":"Life Sci"},{"key":"1816_CR131","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jare.2022.10.013","volume":"50","author":"S Salim","year":"2022","unstructured":"Salim S, Ahmad F, Banu A, Mohammad F (2022) Gut microbiome and Parkinson\u2019s disease: perspective on pathogenesis and treatment. J Adv Res 50:83\u2013105. https:\/\/doi.org\/10.1016\/j.jare.2022.10.013","journal-title":"J Adv Res"},{"key":"1816_CR132","doi-asserted-by":"publisher","first-page":"100932","DOI":"10.1016\/j.bbih.2024.100932","volume":"43","author":"R Sarallah","year":"2025","unstructured":"Sarallah R, Jahani S, Soltani Khaboushan A, Moaveni AK, Amiri M, Majidi Zolbin M (2025) The role of CXCL12\/CXCR4\/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases. Brain Behav Immun Health 43:100932. https:\/\/doi.org\/10.1016\/j.bbih.2024.100932","journal-title":"Brain Behav Immun Health"},{"key":"1816_CR133","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00262-025-04011-5","volume":"74","author":"G Sareen","year":"2025","unstructured":"Sareen G, Mohan M, Mannan A, Dua K, Singh TG (2025) A new era of cancer immunotherapy: vaccines and miRNAs. Cancer Immunol Immunother 74:163. https:\/\/doi.org\/10.1007\/s00262-025-04011-5","journal-title":"Cancer Immunol Immunother"},{"key":"1816_CR134","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41586-025-08700-0","volume":"641","author":"N Sawamoto","year":"2025","unstructured":"Sawamoto N, Doi D, Nakanishi E, Sawamura M, Kikuchi T, Yamakado H, Taruno Y, Shima A, Fushimi Y, Okada T, Kikuchi T, Morizane A, Hiramatsu S, Anazawa T, Shindo T, Ueno K, Morita S, Arakawa Y, Nakamoto Y, Miyamoto S, Takahashi R, Takahashi J (2025) Phase I\/II trial of iPS-cell-derived dopaminergic cells for Parkinson\u2019s disease. Nature 641:971\u2013977. https:\/\/doi.org\/10.1038\/s41586-025-08700-0","journal-title":"Nature"},{"key":"1816_CR135","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.pbr.2019.10.006","volume":"252","author":"AM Schonhoff","year":"2020","unstructured":"Schonhoff AM, Williams GP, Wallen ZD, Standaert DG, Harms AS (2020) Innate and adaptive immune responses in Parkinson\u2019s disease. Prog Brain Res 252:169\u2013216. https:\/\/doi.org\/10.1016\/bs.pbr.2019.10.006","journal-title":"Prog Brain Res"},{"key":"1816_CR136","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1128\/MCB.00657-10","volume":"30","author":"TT Schug","year":"2010","unstructured":"Schug TT, Xu Q, Gao H, Peres-da-Silva A, Draper DW, Fessler MB, Purushotham A, Li X (2010) Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol Cell Biol 30:4712\u20134721. https:\/\/doi.org\/10.1128\/MCB.00657-10","journal-title":"Mol Cell Biol"},{"key":"1816_CR137","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.3390\/medicina59111950","volume":"59","author":"A Sernicola","year":"2023","unstructured":"Sernicola A, Mazzetto R, Tartaglia J, Ciolfi C, Miceli P, Alaibac M (2023) Role of human leukocyte antigen class II in antibody-mediated skin disorders. Medicina 59:1950. https:\/\/doi.org\/10.3390\/medicina59111950","journal-title":"Medicina"},{"key":"1816_CR138","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1126\/scisignal.2005375","volume":"7","author":"S Shinozaki","year":"2014","unstructured":"Shinozaki S, Chang K, Sakai M, Shimizu N, Yamada M, Tanaka T, Nakazawa H, Ichinose F, Yamada Y, Ishigami A, Ito H, Ouchi Y, Starr ME, Saito H, Shimokado K, Stamler JS, Kaneki M (2014) Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65. Sci Signal 7:106. https:\/\/doi.org\/10.1126\/scisignal.2005375","journal-title":"Sci Signal"},{"key":"1816_CR139","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/cells13040296","volume":"13","author":"LD Skou","year":"2024","unstructured":"Skou LD, Johansen SK, Okarmus J, Meyer M (2024) Pathogenesis of DJ-1\/PARK7-mediated Parkinson\u2019s disease. Cells 13:296. https:\/\/doi.org\/10.3390\/cells13040296","journal-title":"Cells"},{"key":"1816_CR140","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.3390\/molecules27175481","volume":"27","author":"A Skrzypczak-Wiercioch","year":"2022","unstructured":"Skrzypczak-Wiercioch A, Sa\u0142at K (2022) Lipopolysaccharide-induced model of neuroinflammation: mechanisms of action, research application and future directions for its use. Molecules 27:5481. https:\/\/doi.org\/10.3390\/molecules27175481","journal-title":"Molecules"},{"key":"1816_CR141","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3233\/JPD-202279","volume":"11","author":"RJ Smeyne","year":"2021","unstructured":"Smeyne RJ, Noyce AJ, Byrne M, Savica R, Marras C (2021) Infection and risk of Parkinson\u2019s disease. J Parkinsons Dis 11:31\u201343. https:\/\/doi.org\/10.3233\/JPD-202279","journal-title":"J Parkinsons Dis"},{"key":"1816_CR142","doi-asserted-by":"publisher","first-page":"676236","DOI":"10.3389\/fimmu.2021.676236","volume":"12","author":"J Srinivasan","year":"2021","unstructured":"Srinivasan J, Lancaster JN, Singarapu N, Hale LP, Ehrlich LIR, Richie ER (2021) Age-related changes in thymic central tolerance. Front Immunol 12:676236. https:\/\/doi.org\/10.3389\/fimmu.2021.676236","journal-title":"Front Immunol"},{"key":"1816_CR143","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","volume":"20","author":"F Stocchi","year":"2024","unstructured":"Stocchi F, Bravi D, Emmi A, Antonini A (2024) Parkinson disease therapy: current strategies and future research priorities. Nat Rev Neurol 20:695\u2013707. https:\/\/doi.org\/10.1038\/s41582-024-01034-x","journal-title":"Nat Rev Neurol"},{"key":"1816_CR144","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12974-020-01911-4","volume":"17","author":"MS Subbarayan","year":"2020","unstructured":"Subbarayan MS, Hudson C, Moss LD, Nash KR, Bickford PC (2020) T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an \u03b1-synuclein rat model of Parkinson\u2019s disease. J Neuroinflammation 17:242. https:\/\/doi.org\/10.1186\/s12974-020-01911-4","journal-title":"J Neuroinflammation"},{"key":"1816_CR145","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","volume":"641","author":"V Tabar","year":"2025","unstructured":"Tabar V, Sarva H, Lozano AM, Fasano A, Kalia SK, Yu KKH, Brennan C, Ma Y, Peng S, Eidelberg D, Tomishima M, Irion S, Stemple W, Abid N, Lampron A, Studer L, Henchcliffe C (2025) Phase I trial of hES cell-derived dopaminergic neurons for Parkinson\u2019s disease. Nature 641:978\u2013983. https:\/\/doi.org\/10.1038\/s41586-025-08845-y","journal-title":"Nature"},{"key":"1816_CR146","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22:657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"key":"1816_CR147","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41531-021-00271-x","volume":"8","author":"J Tian","year":"2022","unstructured":"Tian J, Dai S-B, Jiang S-S, Yang W-Y, Yan Y-Q, Lin Z-H, Dong J-X, Liu Y, Zheng R, Chen Y, Zhang B-R, Pu J-L (2022) Specific immune status in Parkinson\u2019s disease at different ages of onset. NPJ Parkinsons Dis 8:5. https:\/\/doi.org\/10.1038\/s41531-021-00271-x","journal-title":"NPJ Parkinsons Dis"},{"key":"1816_CR148","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023660","volume":"6","author":"TA Tran","year":"2011","unstructured":"Tran TA, Nguyen AD, Chang J, Goldberg MS, Lee J-K, Tansey MG (2011) Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B. PLoS ONE 6:e23660. https:\/\/doi.org\/10.1371\/journal.pone.0023660","journal-title":"PLoS ONE"},{"key":"1816_CR149","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.4110\/in.2020.20.e23","volume":"20","author":"A Trzeciak","year":"2020","unstructured":"Trzeciak A, Pietropaoli AP, Kim M (2020) Biomarkers and associated immune mechanisms for early detection and therapeutic management of sepsis. Immune Netw 20:e23. https:\/\/doi.org\/10.4110\/in.2020.20.e23","journal-title":"Immune Netw"},{"key":"1816_CR150","first-page":"1176","volume":"34","author":"Q Wang","year":"2014","unstructured":"Wang Q, Zhang H, Liu M, Zhang Z, Wei Z, Sun N, Mao T, Zhang Y (2014) P38 MAPK signaling pathway regulates nuclear factor-\u03baB and inducible nitric oxide synthase expressions in the substantia nigra in a mouse model of Parkinson\u2019s disease. Nan Fang Yi Ke Da Xue Xue Bao 34:1176\u20131180","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"1816_CR151","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3389\/fnins.2020.00353","volume":"14","author":"X Wang","year":"2020","unstructured":"Wang X, Sun X, Niu M, Zhang X, Wang J, Zhou C, Xie A (2020) RAGE silencing ameliorates neuroinflammation by inhibition of p38-NF-\u03baB signaling pathway in mouse model of Parkinson\u2019s disease. Front Neurosci 14:353. https:\/\/doi.org\/10.3389\/fnins.2020.00353","journal-title":"Front Neurosci"},{"key":"1816_CR152","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mito.2023.01.007","volume":"69","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wu J, Wang J, He L, Lai H, Zhang T, Wang X, Li W (2023) Mitochondrial oxidative stress in brain microvascular endothelial cells: triggering blood-brain barrier disruption. Mitochondrion 69:71\u201382. https:\/\/doi.org\/10.1016\/j.mito.2023.01.007","journal-title":"Mitochondrion"},{"key":"1816_CR153","doi-asserted-by":"publisher","first-page":"110063","DOI":"10.1016\/j.neuropharm.2024.110063","volume":"257","author":"A Wang","year":"2024","unstructured":"Wang A, Zhong G, Ying M, Fang Z, Chen Y, Wang H, Wang C, Liu C, Guo Y (2024a) Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1\/Parkin pathway. Neuropharmacology 257:110063. https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110063","journal-title":"Neuropharmacology"},{"key":"1816_CR154","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12929-024-01025-6","volume":"31","author":"V Wang","year":"2024","unstructured":"Wang V, Tseng K-Y, Kuo T-T, Huang EY-K, Lan K-L, Chen Z-R, Ma K-H, Greig NH, Jung J, Choi H-I, Olson L, Hoffer BJ, Chen Y-H (2024b) Attenuating mitochondrial dysfunction and morphological disruption with PT320 delays dopamine degeneration in MitoPark mice. J Biomed Sci 31:38. https:\/\/doi.org\/10.1186\/s12929-024-01025-6","journal-title":"J Biomed Sci"},{"key":"1816_CR155","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1515\/revneuro-2014-0067","volume":"26","author":"W Xiang","year":"2015","unstructured":"Xiang W, Chao Z-Y, Feng D-Y (2015) Role of toll-like receptor\/MYD88 signaling in neurodegenerative diseases. Rev Neurosci 26:407\u2013414. https:\/\/doi.org\/10.1515\/revneuro-2014-0067","journal-title":"Rev Neurosci"},{"key":"1816_CR156","doi-asserted-by":"publisher","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","volume":"316","author":"C Yang","year":"2019","unstructured":"Yang C, Hawkins KE, Dor\u00e9 S, Candelario-Jalil E (2019) Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke. Am J Physiol Cell Physiol 316:C135\u2013C153. https:\/\/doi.org\/10.1152\/ajpcell.00136.2018","journal-title":"Am J Physiol Cell Physiol"},{"key":"1816_CR157","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1472-6882-12-82","volume":"12","author":"Q Ye","year":"2012","unstructured":"Ye Q, Ye L, Xu X, Huang B, Zhang X, Zhu Y, Chen X (2012) Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1\/PGC-1\u03b1 signaling pathway. BMC Complement Altern Med 12:82. https:\/\/doi.org\/10.1186\/1472-6882-12-82","journal-title":"BMC Complement Altern Med"},{"key":"1816_CR158","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1158\/0008-5472.CAN-22-3009","volume":"83","author":"F Ye","year":"2023","unstructured":"Ye F, Cai Z, Wang B, Zeng C, Xi Y, Hu S, Qu R, Yuan Z, Yue J, Tian Y, Wang X, Fu X, Li L (2023) TGF\u03b2 antagonizes IFN\u03b3-mediated adaptive immune evasion via activation of the AKT-Smad3-SHP1 axis in lung adenocarcinoma. Cancer Res 83:2262\u20132277. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-3009","journal-title":"Cancer Res"},{"key":"1816_CR159","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1197265","author":"S Yokoyama","year":"2023","unstructured":"Yokoyama S (2023) Genetic polymorphisms of bone marrow stromal cell antigen-1 (BST-1\/CD157): implications for immune\/inflammatory dysfunction in neuropsychiatric disorders. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1197265","journal-title":"Front Immunol"},{"key":"1816_CR160","doi-asserted-by":"publisher","first-page":"105683","DOI":"10.1016\/j.neuint.2024.105683","volume":"175","author":"XiaoLei Zhang","year":"2024","unstructured":"Zhang XiaoLei, Wang Y, Lv J (2024a) STAT4 targets KISS1 to inhibit the oxidative damage, inflammation and neuronal apoptosis in experimental PD models by inactivating the MAPK pathway. Neurochem Int 175:105683. https:\/\/doi.org\/10.1016\/j.neuint.2024.105683","journal-title":"Neurochem Int"},{"key":"1816_CR161","doi-asserted-by":"publisher","first-page":"5072","DOI":"10.3390\/molecules29215072","volume":"29","author":"X Zhang","year":"2024","unstructured":"Zhang X, Zhang H, Huang M, Mei Y, Hu C, Huang C, Zhang H, Wei X, Gao Y, Ma Z (2024b) Ferulic acid interferes with radioactive intestinal injury through the DJ-1-Nrf2 and Sirt1-NF-\u03baB-NLRP3 pathways. Molecules 29:5072. https:\/\/doi.org\/10.3390\/molecules29215072","journal-title":"Molecules"},{"key":"1816_CR162","doi-asserted-by":"publisher","first-page":"106710","DOI":"10.1016\/j.nbd.2024.106710","volume":"202","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zou M, Wu H, Zhu J, Jin T (2024c) The cGAS-STING pathway drives neuroinflammation and neurodegeneration via cellular and molecular mechanisms in neurodegenerative diseases. Neurobiol Dis 202:106710. https:\/\/doi.org\/10.1016\/j.nbd.2024.106710","journal-title":"Neurobiol Dis"},{"key":"1816_CR163","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.nbd.2006.11.012","volume":"26","author":"C Zhao","year":"2007","unstructured":"Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM (2007) TNF-alpha knockout and minocycline treatment attenuates blood brain barrier leakage in MPTP-treated Mice. Neurobiol Dis 26:36\u201346. https:\/\/doi.org\/10.1016\/j.nbd.2006.11.012","journal-title":"Neurobiol Dis"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01816-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01816-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T21:57:41Z","timestamp":1757195861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01816-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":163,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1816"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01816-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The paper is submitted with the consent of all listed authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}